OTC : ANHGY

Mediclinic International plc

$5.49 USD

$0 (0.0%)

Volume
1
Average Volume
0
Market Capitalization
$4.05B
P/E Ratio
25.39
Dividend Yield
0.00%
Price Target
Year High
$5.58
Year Low
$4.62
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$1.79

Industry, Sector & symbol

Stock Exchange OTC
CEO Carel Aron van der Merwe D.A. M.B.Ch.B.
Industry Medical - Care Facilities
Sector Healthcare
Current Symbol ANHGY
CUSIP None
CIK None
Web https://www.mediclinic.com
Phone 27 21 809 6500
Currency USD
Employees 33683
Country ZA

Liquidity

Debt-to-Equity Ratio 0.83
Payout Ratio 0.00
Current Ratio 1.79
Quick Ratio 1.67
Cash Ratio 0.65

Sales & Book Value

Annual Sales -$
Price / Sales 122.87
Cash Flow 0.51
Price / Cash Flow 1059.26
Price / Book 1.27

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecast Upside/Downside %
Consensus Rating N/A
Rating Score(0-5) 0
Research Coverage 1 Analysts

Profitability

EPS (Most Recent Fiscal Year)
Trailing P/E Ratio 25.39
PEG Ratio 0.25
P/E Growth 0.25
Net Income -$
Net Margin 4.67%
Pretax Margin 6.53%
Return on Equity 5.07%
Return on Assets 2.10%

Financials Score

AltmanZ Score
Piotroski Score
Working Capital -
Total Assets -
Ebit -
Market Cap -
Total Liabilities -

Poll Results

About Mediclinic International plc (OTC:ANHGY) Stock

Mediclinic International plc, through its various group entities, manages and operates private healthcare facilities, delivering comprehensive, specialist-driven, and diverse medical care under the Mediclinic and Hirslanden brand names. Its extensive network spans Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom, encompassing 74 hospitals, 20 day clinics, 22 outpatient centers, 5 subacute care facilities, and 2 mental health institutions. These operations include 453 operating theatres and provide approximately 11,538 inpatient beds. Beyond direct patient care, the company engages in a broad array of supporting functions, such as treasury operations, sourcing and managing hospital equipment, providing emergency medical aid, general management services, food and c ... atering, overall healthcare management, and debt collection. It also oversees healthcare personnel and manages its real estate holdings. Furthermore, its activities extend to managing intellectual property and operating medical supply and procurement ventures. Established in 1983, Mediclinic International plc is headquartered in Stellenbosch, South Africa.

Frequently Asked Questions

What is the current Mediclinic International plc (ANHGY) stock price?

Mediclinic International plc(OTC:ANHGY) stock price is $5.49 in the last trading session. During the trading session, ANHGY stock reached the peak price of $5.58 while $4.62 was the lowest point it dropped to. The percentage change in ANHGY stock occurred in the recent session was 0.0% while the dollar amount for the price change in ANHGY stock was $0.

ANHGY's industry and sector of operation?

The OTC listed ANHGY is part of Medical - Care Facilities industry that operates in the broader Healthcare sector.

Who are the executives of ANHGY?

Petrus Jurgens Myburgh | Group Chief Financial Officer & Executive Director
Dirk C. Le Roux | Group Chief Information Officer
Biren Valodia | Chief Marketing Officer of Medi-Clinic Southern Africa
James Arnold | Head of Investor Relations
Koert H. S. Pretorius B.Compt | Group Chief Operating Officer

How many employees does ANHGY have?

Number of ANHGY employees currently stands at 33683. ANHGY operates from 25 Du Toit Street, Stellenbosch, None 7600, ZA.

Link for ANHGY official website?

Official Website of ANHGY is: https://www.mediclinic.com

How do I contact ANHGY?

ANHGY could be contacted at phone #27 21 809 6500 and can also be accessed through its website. ANHGY operates from 25 Du Toit Street, Stellenbosch, None 7600, ZA.

How many shares of ANHGY are traded daily?

The average number of ANHGY shares traded daily for last 3 months was 0.

What is the market cap of ANHGY currently?

The market value of ANHGY currently stands at $4.05B with its latest stock price at $5.49